Back

Unicycive investors face Nov. 2 deadline to seek lead-plaintiff role

Verifying
  • Law Offices of Frank R. Cruz announced an opportunity for Unicycive investors to seek lead-plaintiff status.
  • November 2, 2026, is the stated deadline for investors to pursue that role.
  • The complaint alleges undisclosed manufacturing, FDA and OLC approval risks.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.